Raising the Woof: CBD of Denver Signs Deal with Pawell for Pet CBD in Europe
Ryan Allway
July 28th, 2022
News, Top News
Denver, Colorado–(Newsfile Corp. – July 28, 2022) – Mellow, the wholly owned subsidiary of CBD of Denver, Inc. (OTC Pink: CBDD), is pleased to announce a strategic partnership with Pawell to sell and distribute their market-leading Pet CBD products through Switzerland and the wider EU markets via a multi-channel go-to-market strategy.
Pawell is the French and European leader in CBD products for pets with an exclusive range of products targeted at cats and dogs.
The EU Pet CBD market is in its early stages of growth and is estimated to be growing at a CAGR of 59% through to 2028, making it one of the most attractive and fast-growing sub-sectors of the European Hemp and CBD markets. CBD products for pets are typically bought for the purposes of pain relief and also for the treatment of anxiety, and with the growth in the Pet market seeing astronomical growth during the global COVID-19 pandemic, the opportunity is attractive.
The addition of these products fits very well with the burgeoning branded CBD offering that is coming out of the Mellow stable and with its own retail stores, eCommerce channels, wholesale distribution partners and also in-house digital and performance marketing agency, Grow by Mellow, the Pawell offering is a great addition. James Storie-Pugh, co-founder of Mellow, explains further that “Pawell is a fantastic brand and already has an incredible market position and product range. To be able to bring them to the Swiss market and also help them expand beyond their own borders is a wonderful opportunity and so we’re thrilled to be able to announce this partnership. Furthermore, the Pet market is growing incredibly quickly and we know that the Pet CBD market is something that the Swiss consumer has adopted incredibly quickly. Our plan is to have the Pawell range of products available across our entire ecosystem and also help the brand extend into new territories as we also grow our presence.”
The CEO and founder of Pawell, Timothe Benabou, added, “Working with mellow gives us a unique opportunity to enter new European markets with our award-winning products and access a whole new customer base. Our goal is to continue to build upon our European statues as a leading CBD brand for pets and working with mellow help simply the speed up the process of international expansion.”
About CBD of Denver, Inc.
CBD of Denver, Inc. owns 100% of Rockflowr, a full-line Distributor of CBD and Cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe. As a Cannabis Roll-Up company CBD of Denver, Inc. is focused on using equity to acquire profitable assets at attractive valuations to create value for all our shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis. Through the Rockflowr brand CBDD has been able to build a very strong European customer base by focusing on top quality products and meaningful customer relationships.
Follow CBDD & Mellow on LinkedIn:
https://www.linkedin.com/company/cbd-of-denver/
https://www.linkedin.com/company/mellow-store/
About Mellow
Mellow group operates as a multi-brand eCommerce Marketplace, a full-service digital & performance marketing agency, as well as a market expansion service into the Asian markets. Recently acquired by CBD of Denver, Mellow is playing a key role in expanding the CBDD business revenue streams, as well as diversifying the brand portfolio, as part of a commercial roll-up strategy. With offices in the UK and Switzerland CBDD is able to offer and end-to-end service proposition for brands wanting to enter and/or operate across the UK / EU markets, including manufacturing, production, supply-chain, distribution, eCommerce and Marketing.
Visit CBDD & Mellow:
Investor Contact
Todd McKnight
RedChip Companies
1-800-733-2447
CBDD@redchip.com
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Revive Therapeutics’ cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease.
Zenabis owns 660,000 square feet of high quality indoor facility space, as well as 2.1 million square feet of greenhouse space that will be dedicated to cannabis production once fully built-out.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
